BioCentury | Aug 29, 2020
Deals

Data Bytes: Cryoport deals show continued interest in cell, gene therapy manufacturing and supply chain players

...viral vector manufacturing unit; and the $21.4 billion purchase of GE Life Sciences’ biopharma business by Danaher Corp....
...line. Amanda Micklus Spark Therapeutics Celgene Corp. Juno Therapeutics Inc. Sorrento Therapeutics Inc. SmartPharm Therapeutics Inc. Thermo Fisher Scientific Inc. Brammer Bio Merck KGaA BioReliance Corp. Danaher Corp. Chart...
BioCentury | Jul 25, 2020
Product Development

NIH, HHS fast-tracking point-of-care, pooled tech as way out of testing crunch

...NASDAQ:HOLX) are in limited supply, and point-of-care molecular tests from the Cepheid Inc. unit of Danaher Corp....
BioCentury | Jun 11, 2020
Product Development

Emerging COVID-19 serology tests aim for neutralizing antibodies

...But two other diagnostic giants, Siemens Healthineers AG (Xetra:SHL) and the Beckman Coulter unit of Danaher Corp....
...SARS-CoV-2 N - SARS-CoV-2 nucleocapsid protein SARS-CoV-2 S - SARS-CoV-2 spike protein Karen Tkach Tuzman, Associate Editor Danaher Corp. Siemens GenScript...
BioCentury | May 20, 2020
Product Development

Roche, Abbott say sample collection differences hampered COVID-19 sensitivity in independent studies

...large fraction of positive samples caught by another rapid test from the Cepheid unit of Danaher Corp....
BioCentury | May 14, 2020
Product Development

New scrutiny prompts withdrawal, re-evaluation of two rapid COVID-19 tests

...fraction of positive cases detected by the Xpert Xpress test from the Cepheid unit of Danaher Corp....
BioCentury | Apr 30, 2020
Deals

AstraZeneca to make COVID-19 vaccine with roots in Oxford’s CEPI-funded MERS project

...The group includes the Vaccines Manufacturing and Innovation Centre; Pall Life Sciences, a unit of Danaher Corp....
BioCentury | Apr 15, 2020
Politics, Policy & Law

Medicare raises payments to increase high-throughput COVID-19 testing

...Panther Fusion System from Hologic Inc. (NASDAQ:HOLX); GeneXpert Infinity System from the Cepheid unit of Danaher Corp....
BioCentury | Mar 28, 2020
Product Development

COVID-19 crisis spurs innovation in rapid diagnostic technologies

...test authorized by FDA was the Xpert Xpress SARS-CoV-2 test from the Cepheid unit of Danaher Corp....
BioCentury | Mar 28, 2020
Product Development

COVID-19 diagnostic tech tableau

...can be performed at the bedside. In the last week, the Cepheid Inc. subsidiary of Danaher Corp....
...can be found at https://www.biocentury.com/coronavirus . Targets TCR - T cell receptor Karen Tkach Tuzman, Associate Editor Danaher Corp. Adaptive...
BioCentury | Feb 13, 2020
Product Development

COVID-19 update: Remdesivir readout in weeks; hospital-use diagnostic under development; antibodies advancing

...to deliver point-of-care results in about 30 minutes,” the company said. Cepheid, a unit of Danaher Corp....
Items per page:
1 - 10 of 59
BioCentury | Aug 29, 2020
Deals

Data Bytes: Cryoport deals show continued interest in cell, gene therapy manufacturing and supply chain players

...viral vector manufacturing unit; and the $21.4 billion purchase of GE Life Sciences’ biopharma business by Danaher Corp....
...line. Amanda Micklus Spark Therapeutics Celgene Corp. Juno Therapeutics Inc. Sorrento Therapeutics Inc. SmartPharm Therapeutics Inc. Thermo Fisher Scientific Inc. Brammer Bio Merck KGaA BioReliance Corp. Danaher Corp. Chart...
BioCentury | Jul 25, 2020
Product Development

NIH, HHS fast-tracking point-of-care, pooled tech as way out of testing crunch

...NASDAQ:HOLX) are in limited supply, and point-of-care molecular tests from the Cepheid Inc. unit of Danaher Corp....
BioCentury | Jun 11, 2020
Product Development

Emerging COVID-19 serology tests aim for neutralizing antibodies

...But two other diagnostic giants, Siemens Healthineers AG (Xetra:SHL) and the Beckman Coulter unit of Danaher Corp....
...SARS-CoV-2 N - SARS-CoV-2 nucleocapsid protein SARS-CoV-2 S - SARS-CoV-2 spike protein Karen Tkach Tuzman, Associate Editor Danaher Corp. Siemens GenScript...
BioCentury | May 20, 2020
Product Development

Roche, Abbott say sample collection differences hampered COVID-19 sensitivity in independent studies

...large fraction of positive samples caught by another rapid test from the Cepheid unit of Danaher Corp....
BioCentury | May 14, 2020
Product Development

New scrutiny prompts withdrawal, re-evaluation of two rapid COVID-19 tests

...fraction of positive cases detected by the Xpert Xpress test from the Cepheid unit of Danaher Corp....
BioCentury | Apr 30, 2020
Deals

AstraZeneca to make COVID-19 vaccine with roots in Oxford’s CEPI-funded MERS project

...The group includes the Vaccines Manufacturing and Innovation Centre; Pall Life Sciences, a unit of Danaher Corp....
BioCentury | Apr 15, 2020
Politics, Policy & Law

Medicare raises payments to increase high-throughput COVID-19 testing

...Panther Fusion System from Hologic Inc. (NASDAQ:HOLX); GeneXpert Infinity System from the Cepheid unit of Danaher Corp....
BioCentury | Mar 28, 2020
Product Development

COVID-19 crisis spurs innovation in rapid diagnostic technologies

...test authorized by FDA was the Xpert Xpress SARS-CoV-2 test from the Cepheid unit of Danaher Corp....
BioCentury | Mar 28, 2020
Product Development

COVID-19 diagnostic tech tableau

...can be performed at the bedside. In the last week, the Cepheid Inc. subsidiary of Danaher Corp....
...can be found at https://www.biocentury.com/coronavirus . Targets TCR - T cell receptor Karen Tkach Tuzman, Associate Editor Danaher Corp. Adaptive...
BioCentury | Feb 13, 2020
Product Development

COVID-19 update: Remdesivir readout in weeks; hospital-use diagnostic under development; antibodies advancing

...to deliver point-of-care results in about 30 minutes,” the company said. Cepheid, a unit of Danaher Corp....
Items per page:
1 - 10 of 59